dantrolene has been researched along with Drug Withdrawal Symptoms in 8 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 29-year-old man with C6 tetraplegia (ASIA A) using an implanted baclofen pump and intrathecal catheter infusion system for spasticity control developed severe spasticity, hyperthermia, hypotension, rhabdomyolysis, and disseminated intravascular coagulation after catheter disconnection." | 7.70 | Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. ( Christopherson, MW; Reeves, RK; Stolp-Smith, KA, 1998) |
| "A 29-year-old man with C6 tetraplegia (ASIA A) using an implanted baclofen pump and intrathecal catheter infusion system for spasticity control developed severe spasticity, hyperthermia, hypotension, rhabdomyolysis, and disseminated intravascular coagulation after catheter disconnection." | 3.70 | Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure. ( Christopherson, MW; Reeves, RK; Stolp-Smith, KA, 1998) |
| "In the patients with Parkinson's disease, it is sometimes provoked by discontinuation of anti-Parkinsonism agents." | 1.32 | A case of malignant syndrome associated with a parkinsonism patient. ( Nomura, S; Sanga, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (25.00) | 18.7374 |
| 1990's | 3 (37.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sanga, M | 1 |
| Nomura, S | 1 |
| Linazasoro, G | 1 |
| Van Blercom, N | 1 |
| Castro, A | 1 |
| Dapena, MD | 1 |
| Ward, C | 1 |
| Khorasani, A | 1 |
| Peruzzi, WT | 1 |
| Cape, G | 1 |
| Reeves, RK | 1 |
| Stolp-Smith, KA | 1 |
| Christopherson, MW | 1 |
| Bone, GH | 1 |
| Majchrowicz, E | 1 |
| Martin, PR | 1 |
| Linnoila, M | 1 |
| Nutt, DJ | 1 |
| Rosse, R | 1 |
| Ciolino, C | 1 |
8 other studies available for dantrolene and Drug Withdrawal Symptoms
| Article | Year |
|---|---|
A case of malignant syndrome associated with a parkinsonism patient.
Topics: Antiparkinson Agents; Dantrolene; Fluid Therapy; Humans; Male; Middle Aged; Muscle Relaxants, Centra | 2003 |
Subthalamic deep brain stimulation masking possible malignant syndrome in Parkinson disease.
Topics: Analgesics, Non-Narcotic; Anti-Infective Agents; Antiparkinson Agents; Combined Modality Therapy; Co | 2004 |
Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
Topics: Aged; Antiparkinson Agents; Confusion; Dantrolene; Deep Brain Stimulation; Dehydration; Dopamine Age | 2005 |
Dantrolene treatment for abrupt intrathecal baclofen withdrawal.
Topics: Adult; Baclofen; Dantrolene; Fever; Humans; Male; Muscle Spasticity; Spinal Cord Injuries; Substance | 1995 |
Neuroleptic malignant syndrome--a cautionary tale and a surprising outcome.
Topics: Activities of Daily Living; Adaptation, Psychological; Adult; Antisocial Personality Disorder; Combi | 1994 |
Hyperthermia, rhabdomyolysis, and disseminated intravascular coagulation associated with baclofen pump catheter failure.
Topics: Adult; Baclofen; Catheters, Indwelling; Dantrolene; Disseminated Intravascular Coagulation; Equipmen | 1998 |
A comparison of calcium antagonists and diazepam in reducing ethanol withdrawal tremors.
Topics: Animals; Brain Chemistry; Calcium Channel Blockers; Dantrolene; Diazepam; Ethanol; Male; Nimodipine; | 1989 |
Dopamine agonists and neuroleptic malignant syndrome.
Topics: Alzheimer Disease; Amantadine; Basal Ganglia Diseases; Bromocriptine; Dantrolene; Humans; Male; Midd | 1985 |